Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone-tazobactam (4:1) vs (3:1) in moderate to severe lower respiratory and urinary tract infections
CTR20132616Phase 2Active
- Sponsor
- Hainan Helpson Medical & Biotechnology
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceftriaxone + tazobactam in pulmonary infection, urinary tract infection (UTI), pyelonephritis, sponsored by Hainan Helpson Medical & Biotechnology. Started Jan 2014; status: active.
02
Drugs
ceftriaxone + tazobactam
03
Conditions
pulmonary infectionurinary tract infection (UTI)pyelonephritis
Beyond the preview
Go deeper on CTR20132616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132616.